Migraleve Pink tablets combine paracetamol 500mg, codeine phosphate 8mg, and buclizine hydrochloride 6.25mg to treat migraine attacks including the associated nausea and vomiting.
Available as a pharmacy medicine (P) without a prescription, they are suitable for adults and young people aged 12 and over. Each pack contains 24 tablets.
Courier Pharmacy provides expert pharmacist guidance to help you use Migraleve Pink safely and effectively within your wider migraine management.
Migraleve Pink Tablets are a triple-action pharmacy medicine for the acute treatment of migraine attacks in adults and young people aged 12 and over. Each tablet combines pain relief with support for nausea, which is often the worst part of a migraine.
Each Migraleve Pink tablet contains paracetamol 500mg to ease pain and codeine phosphate 8mg for extra pain relief. It also contains buclizine hydrochloride 6.25mg, an antihistamine that helps reduce nausea and vomiting. As a result, you can feel more comfortable during an attack and keep your dose down.
What sets Migraleve Pink Tablets apart from standard co-codamol is the buclizine. Migraine nausea can make it hard to take tablets, and it can also affect how well your body absorbs them. However, when you tackle nausea at the same time, you may find it easier to take your medicine and get more reliable relief. Put simply: a tablet you can keep down has a better chance of doing its job.
Many people use Migraleve Pink as the first step in the Migraleve two-colour system. You take the pink tablets at the start of an attack, then switch to yellow tablets (paracetamol + codeine, without buclizine) for later doses once nausea settles. That said, you can also buy Migraleve Pink Tablets on their own.
If you’re not sure whether Migraleve Pink alone or the combined pink-and-yellow pack suits your migraine pattern, we can help. Our pharmacists at Courier Pharmacy can talk you through the options, so you choose the safest fit.
If you know migraine, you know the feeling. The aura that arrives like a weather front. The slow dread as you realise this one is settling in. The nausea that turns the thought of food into a horror story.
Migraleve Pink is a UK Pharmacy migraine treatment that pairs codeine and paracetamol with an anti-sickness antihistamine in a single tablet, giving you a one-step approach for both the headache and the queasiness at the start of an attack.
At Courier Pharmacy, we believe pain relief should suit the person, not the marketing budget. Whether you’re managing chronic migraine, hormonal migraine, or the occasional knock-out attack, this page is here to help you decide whether Migraleve Pink fits your situation.
Five key takeaways
Migraleve Pink is a UK Pharmacy (P) medicine for the short-term relief of acute migraine attacks, containing paracetamol 500mg, codeine phosphate 8mg, and buclizine hydrochloride 6.25mg in each pink tablet for combined pain and nausea relief.
Take 2 pink tablets at the first sign of migraine. Maximum 2 pink tablets in 24 hours, because the buclizine content should not be repeated within the same attack.
Because Migraleve Pink contains codeine, it must not be used for more than three days continuously without medical advice, due to the risk of addiction and medication-overuse headache.
Migraleve Pink is suitable for adults and adolescents aged 12 and over, but not for under-12s and not for under-18s who have had tonsils or adenoids removed for obstructive sleep apnoea.
Courier Pharmacy supplies Migraleve Pink with full pharmacist oversight, personalised guidance, and free fortnightly community clinics in Derby.
Migraine is a common problem
Migraine is the world’s third most prevalent illness and one of the leading causes of years lived with disability globally. Despite this, it is persistently under-diagnosed and under-treated, with many sufferers managing attacks alone using OTC medicines rather than receiving the preventive and acute prescription treatments that could transform their quality of life. Migraleve Pink tablets occupy a useful position in this landscape: accessible, specifically formulated for migraine rather than generic pain, and effective for mild to moderate attacks when used appropriately.
It’s all about the buclizine
The buclizine component is what makes Migraleve Pink distinct from other codeine-containing analgesics. Nausea accompanies around 90 percent of migraine attacks and vomiting around a third. For someone in the middle of a severe attack, nausea alone can be as debilitating as the headache, and it creates a practical problem: if you cannot keep a tablet down, you are not getting the pain relief. Buclizine reduces nausea centrally, improving both comfort and the likelihood that the paracetamol and codeine are absorbed and retained.
Three day max
The three-day maximum is especially relevant in the context of migraine. Medication overuse headache (MOH), sometimes called rebound headache, develops when analgesics are used too frequently. The brain adapts to regular analgesic exposure and becomes more pain-sensitive in their absence, which paradoxically increases both headache frequency and severity. Triptans, paracetamol, NSAIDs, and codeine-containing products are all capable of causing MOH. If your migraine pattern is worsening and you are using acute medicines frequently, this is a conversation worth having with your GP rather than increasing the dose or frequency of OTC analgesia.
Other treatment options
For people with recurring or complex migraine, including those managing it alongside other chronic conditions, a more comprehensive management plan is usually more effective than repeated short courses of acute OTC treatment. Prescription options including triptans, preventive beta-blockers, topiramate, and CGRP antagonists exist and are often dramatically more effective for frequent or severe migraine.
Our pharmacists at Courier Pharmacy can help you identify whether it is worth having that conversation with your GP, and our drop-in clinics in Derby are a relaxed space to explore these questions without pressure.
Pink and Yellow Migraleve tablets
The pink and yellow Migraleve system is worth understanding. Pink tablets are taken at the start of an attack when nausea is most likely to be present, providing the full triple-action combination. Yellow tablets, which contain paracetamol and codeine without buclizine, are used for subsequent doses once nausea has settled, avoiding unnecessary antihistamine exposure across a multi-day course. If your attacks are typically short-lived or if nausea is not a significant feature for you, a pharmacist can help you decide whether the pink-only pack meets your needs or whether the combined system would work better.
Five key facts
Buclizine hydrochloride, the antiemetic ingredient in Migraleve Pink, is a piperazine antihistamine that blocks H1 receptors in the vomiting centre of the brain, making it specifically effective against motion-related and migraine-associated nausea.
Gastric stasis during a migraine attack slows tablet absorption; taking Migraleve Pink early in an attack, before stasis develops, significantly improves the reliability of the medicine.
The 8mg codeine dose adds meaningful analgesia beyond paracetamol for most people, but the codeine component also means this is not a medicine for daily or frequent use.
Medication overuse headache is a particular concern with migraine. Using any analgesic on more than ten to fifteen days per month, including Migraleve Pink, can worsen headache frequency over time.
People who experience migraine with aura should be aware that combined oral contraceptives and migraine with aura together represent a significant cardiovascular risk factor; this has no direct bearing on Migraleve Pink but is worth knowing in the context of overall migraine management.
Treatment dosage Migraleve Pink
At the first sign of a migraine, adults and adolescents aged 12 and over take 2 pink tablets together with water. The full daily maximum is 2 pink tablets in 24 hours; the buclizine in each tablet means a repeat dose should not be taken within the same 24-hour period because of the risk of excessive drowsiness and anticholinergic effects.
If migraine pain persists four hours after the pink dose and continued pain relief is needed, the appropriate follow-up is either the Migraleve Yellow tablets (paracetamol and codeine only, without buclizine) or a different paracetamol-free analgesic such as ibuprofen, taken in line with that product’s own dosing rules. Never combine Migraleve Pink with another paracetamol-containing product within the same 24 hours.
Children aged 10 to 12 years can take a reduced dose of 1 pink tablet at onset, although we generally recommend a clinician’s input for migraine treatment in this age group. Children under 10 should not take Migraleve. Adolescents aged 12 to 18 who have had their tonsils or adenoids removed for obstructive sleep apnoea must not take Migraleve because of the codeine breathing risk.
Migraleve Pink must not be taken for more than three days continuously without seeking medical advice. This is because codeine can cause addiction with continuous use, and using painkillers regularly for headache can paradoxically cause more headaches (medication-overuse headache). If migraines are happening more than once a week, talk to a clinician about preventive treatment rather than continuing to treat with Migraleve.
Migraines are not an ordinary headaches
Migraine isn’t just a bad headache. It’s a neurological condition with phases (prodrome, aura in some people, headache, postdrome) and a constellation of symptoms including light and sound sensitivity, nausea, vomiting, and cognitive fog. Effective migraine treatment usually has to address multiple symptoms at once, not just pain.
Migraleve Pink’s combination approach reflects that reality. Paracetamol plus codeine gives stronger analgesia than paracetamol alone, and buclizine is an antihistamine with anti-nausea and mildly sedative properties that can help when a migraine is making you feel sick. The single-dose design is intentional: the buclizine in the pink tablets lasts several hours, so a single pink dose at attack onset is usually enough for the nausea side of things, even if the pain itself needs additional cover later in the attack.
Migraleve Pink is not a triptan
It’s worth being honest about what Migraleve Pink isn’t. It’s not a triptan, which is the migraine-specific drug class your GP can prescribe and which works on serotonin receptors to abort the attack rather than just dampen its symptoms. For people whose migraines are frequent or severe, a triptan plus a preventer may be a more effective long-term plan than repeated Migraleve courses. It also isn’t designed to provide all-day pain cover on its own; if you typically need follow-up analgesia four hours after the onset dose, the Migraleve Complete pack or a paracetamol-free follow-up like ibuprofen is the right plan.
Migraines the bigger picture
Many of our patients arrive after years of being told their headaches are tension or stress. We don’t subscribe to that framing for clear migraine patterns. Whether you’re managing chronic migraine, hormonal migraine, fibromyalgia overlap, MCAS care, or chronic fatigue care that fits your life, the goal is to find a regimen that respects your body’s signals rather than overriding them.
The bigger picture for any migraine plan involves trigger identification, sleep, hydration, regular meals, and where appropriate, prescriber-supervised preventive medication. Acute treatments like Migraleve Pink are a tool, not the whole toolkit. Our community work in Derby is one way we try to live up to that.
Why choose Courier Pharmacy for Migraleve Pink
We started Courier Pharmacy because too many people were being handed codeine medicines like takeaway flyers, with no conversation about how they fit into a longer-term migraine plan. Personalisation means looking at your migraine pattern, frequency, other medicines, and your wider health picture, then deciding together whether Migraleve Pink fits. For frequent migraines, we’ll also flag whether referral for preventive treatment makes sense.
Guidance carries through after the order goes out. Our GPhC-registered pharmacists are reachable for the smaller questions that often go unasked: how do I avoid medication-overuse headache? Should I be tracking my migraines? Is it time to think about a triptan instead? Our medical lead, the figure behind much of our clinical thinking, is Dr Ada Jex-Cori, an evidence-led, community-rooted clinician who built her practice on the belief that people with chronic pain conditions deserve to be heard.
Trust is the part that has to be earned, not claimed. We’re a UK-regulated pharmacy, we publish our processes, we tell you when something isn’t suitable, and we’d rather lose a sale than place a codeine-containing medicine where it doesn’t belong. Whether you’re navigating chronic migraine, hormonal migraine, fibromyalgia support, MCAS care, or chronic fatigue care that fits your life, we’ll meet you where you are.
Buy Migraleve Pink from Courier Pharmacy
Migraleve Pink is a Pharmacy (P) medicine that contains codeine. That means you don’t need a prescription, but the sale must be supervised by a pharmacist who’s checked the product is appropriate for your situation, particularly given the codeine content and the three-day continuous-use limit. Here’s how the process works at Courier Pharmacy:
Complete a quick online consultation
A UK GPhC-registered pharmacist reviews your answers
If suitable, your order is approved
We dispense and deliver discreetly to your door
If it isn’t suitable for you, we’ll explain why and suggest the next best option. Sometimes that’s Migraleve Complete (the combination pink and yellow pack) for attacks where you typically need follow-up cover, sometimes a different acute migraine treatment, sometimes a referral for prescription options like triptans, and sometimes a discussion about preventive treatment if attacks are frequent. We also run free fortnightly drop-in clinics and talks at Insomnia, Derby, 12 to 1pm. No appointment, no cost, no obligation.
Summary
A UK Pharmacy pack of pink tablets for the start of an acute migraine attack
Each pink tablet targets both migraine pain and the nausea or vomiting that often accompany it
Designed for the onset of an attack rather than continued pain relief through the day
Strictly short-term use; no more than three days continuously without medical advice
Available from Courier Pharmacy with pharmacist-led advice and discreet UK delivery
Active ingredients in Migraleve Pink tablets
Each Migraleve Pink tablet contains three active ingredients, each addressing a different aspect of a migraine attack. Paracetamol 500mg provides central analgesic and antipyretic action, raising the pain threshold in the brain and spinal cord without the gastric irritation associated with NSAIDs.
Codeine phosphate 8mg is a mild opioid prodrug converted to morphine by the liver enzyme CYP2D6, providing additional analgesia beyond paracetamol's reach.
Buclizine hydrochloride 6.25mg is a piperazine-class H1 antihistamine with antiemetic and mild sedative properties, working on the chemoreceptor trigger zone and the vomiting centre in the brainstem to suppress nausea and vomiting.
The combination is logical and well considered. Paracetamol and codeine address the pain through two complementary pathways. Buclizine addresses the nausea that both impairs quality of life during an attack and compromises the absorption of the analgesic components. Together, the three ingredients target migraine as the multi-symptom neurological event it is, rather than treating it as a simple headache. The relatively low doses of each ingredient keep the side effect profile manageable for the intended short-course use.
What are Migraleve Pink tablets used for?
Migraleve Pink tablets are specifically licensed for the treatment of migraine attacks, including the nausea and vomiting that typically accompany them. They are not a general-purpose headache tablet and are not intended for tension headache, cluster headache, or non-specific pain. The presence of buclizine makes them particularly appropriate for migraine with associated nausea, which covers the majority of migraine presentations.
They are indicated for adults and young people aged 12 and over experiencing an acute migraine attack. They work best when taken at the earliest sign of an attack, which for some people means at the onset of aura or premonitory symptoms, and for others at the very first indication of headache. Waiting until the pain is severe reduces both the speed and reliability of response.
Migraleve Pink is an acute treatment for individual attacks, not a preventive medicine. If you are experiencing frequent migraines, four or more per month is a common threshold at which preventive treatment is considered, the right conversation is with your GP about whether a preventive strategy is appropriate. Using Migraleve Pink or any acute analgesic too frequently does not prevent future attacks and, beyond a certain threshold, actively worsens migraine frequency through the mechanism of medication overuse headache.
How to use Migraleve Pink
Take 2 pink tablets together with a glass of water at the very first sign of a migraine. Early treatment matters; the longer an attack is allowed to develop, the harder it becomes to abort. If you experience a typical aura phase, take the pink tablets at the start of the aura rather than waiting for the headache to start.
If pain persists four hours after the pink dose, do not take another pink tablet within the same 24 hours. The appropriate follow-up is either Migraleve Yellow (paracetamol and codeine only) up to a maximum of 6 yellow tablets in 24 hours, or a paracetamol-free option such as ibuprofen taken in line with its own dosing rules. Don't take Migraleve Pink for more than three days continuously without medical advice.
Practical tips from our pharmacists: Migraleve Pink works best when taken with water and ideally with a small amount of food if you can manage it; lie in a dark, quiet room if possible while waiting for the tablets to work; don't drive immediately after taking the pink tablets because buclizine can cause drowsiness; and keep a migraine diary, including how the attack responded to Migraleve Pink, so you can spot patterns over time.
What are Migraleve Pink tablets for?
Migraleve Pink tablets are specifically licensed for the treatment of migraine attacks, including the nausea and vomiting that typically accompany them. They are not a general-purpose headache tablet and are not intended for tension headache, cluster headache, or non-specific pain. The presence of buclizine makes them particularly appropriate for migraine with associated nausea, which covers the majority of migraine presentations.
They are indicated for adults and young people aged 12 and over experiencing an acute migraine attack. They work best when taken at the earliest sign of an attack, which for some people means at the onset of aura or premonitory symptoms, and for others at the very first indication of headache. Waiting until the pain is severe reduces both the speed and reliability of response.
Migraleve Pink is an acute treatment for individual attacks, not a preventive medicine. If you are experiencing frequent migraines, four or more per month is a common threshold at which preventive treatment is considered, the right conversation is with your GP about whether a preventive strategy is appropriate. Using Migraleve Pink or any acute analgesic too frequently does not prevent future attacks and, beyond a certain threshold, actively worsens migraine frequency through the mechanism of medication overuse headache.
Warnings and precautions for Migraleve Pink tablets
Do not take Migraleve Pink tablets if you are allergic to paracetamol, codeine phosphate, buclizine hydrochloride, or any other ingredient in the tablets. Do not give to children under 12. The medicine is contraindicated in people known to be ultra-rapid metabolisers of codeine, in those with significant respiratory depression or obstructive airways disease, and in those with severe hepatic impairment. People with closed-angle glaucoma should not take this medicine due to the anticholinergic properties of buclizine, which can increase intraocular pressure. Similarly, buclizine's anticholinergic effects make it unsuitable for people with urinary retention or those with conditions worsened by reduced secretions.
Codeine dependence is a documented risk with any codeine-containing product. Within a properly observed three-day course, the risk is low for most people, but those with a history of substance misuse or addiction should discuss alternatives with their pharmacist. Drowsiness from both codeine and buclizine is more pronounced than with paracetamol alone; do not drive or operate heavy machinery until you know how this combination affects you.
Medication overuse headache is a particular concern for frequent migraine sufferers using Migraleve Pink. Using any analgesic on more than ten to fifteen days per month can worsen headache patterns over time. If you are using Migraleve Pink this frequently, the appropriate response is a GP review rather than continued OTC self-management. Preventive migraine treatments, which are prescribed rather than purchased over the counter, can dramatically reduce attack frequency and the need for acute medicines.
Paracetamol liver toxicity remains the most serious safety concern. Do not take Migraleve Pink alongside any other paracetamol-containing medicine, including cold remedies, flu treatments, or other combination analgesics. The maximum safe adult daily dose of paracetamol is 4000mg. People with liver disease, those who drink alcohol regularly, and those who are underweight should use paracetamol-containing products with caution and ideally under medical supervision.
Pregnancy and breastfeeding: codeine is not recommended during pregnancy, particularly in the third trimester, and should not be taken by breastfeeding mothers. Buclizine has a limited safety evidence base in pregnancy and should also be avoided. If you are pregnant or breastfeeding and experiencing migraine, speak to your midwife or GP about safe management options before taking Migraleve Pink.
Side effects of Migraleve Pink tablets
The most predictable side effects of Migraleve Pink relate to its component ingredients. Drowsiness is more pronounced than with paracetamol-codeine combinations that do not contain an antihistamine, because both codeine and buclizine have sedating properties. Many migraine sufferers find this sedation welcome during an attack, as rest in a dark room is often the most effective non-pharmacological measure. However, it does mean Migraleve Pink is not suitable for situations where you need to remain alert.
Constipation, nausea (paradoxically, buclizine reduces nausea but does not eliminate it in all patients), dry mouth, blurred vision, and difficulty urinating are less common side effects associated primarily with the anticholinergic properties of buclizine and the opioid properties of codeine. Dizziness and lightheadedness may occur, particularly on standing. These effects are generally mild and resolve as the medicine is eliminated from the body.
Rare but serious side effects include severe allergic reactions including anaphylaxis, serious skin reactions, respiratory depression particularly in ultra-rapid codeine metabolisers, liver damage from paracetamol toxicity in cases of overdose or in those with underlying liver vulnerability, and acute angle-closure glaucoma in predisposed individuals. If you experience difficulty breathing, severe skin reactions, chest pain, unusual confusion, or eye pain with visual changes after taking Migraleve Pink, seek emergency medical attention immediately.
Drug interactions with Migraleve Pink tablets
The interaction profile of Migraleve Pink covers all three active ingredients. Tell your pharmacist about every medicine you are taking, including prescription drugs, OTC products, and herbal remedies, before purchasing this product.
Other paracetamol-containing products are the most clinically common interaction risk. Many OTC medicines sold for cold, flu, and general pain relief contain paracetamol. Taking them alongside Migraleve Pink can easily result in exceeding the 4000mg daily paracetamol limit. Always check the ingredient list of every product you are combining.
CNS depressants interact with both the codeine and buclizine components of Migraleve Pink. Alcohol, benzodiazepines, other opioids, sedating antihistamines, tricyclic antidepressants, and antipsychotics all have additive sedative and respiratory depressant effects. The combination with Migraleve Pink produces greater drowsiness and, at higher doses, potentially dangerous respiratory depression. Avoid alcohol completely during a course of Migraleve Pink.
Anticholinergic interactions are relevant because of buclizine's anticholinergic properties. Medicines with anticholinergic activity, including some antidepressants, antispasmodics, bladder medications, and older antihistamines, can have additive effects with buclizine, increasing the risk of dry mouth, blurred vision, urinary retention, and confusion, particularly in older adults. If you are taking any medicines in this category, discuss suitability with your pharmacist before taking Migraleve Pink.
Monoamine oxidase inhibitors (MAOIs) are contraindicated with codeine and should not be taken within 14 days of each other. Serotonergic medicines, including SSRIs, SNRIs, and triptans, may interact with codeine at higher doses through serotonin syndrome risk, though this is unlikely at the 8mg dose in Migraleve Pink; mention all psychiatric and migraine-specific medicines to your pharmacist nonetheless. CYP2D6 inhibitors such as fluoxetine and paroxetine reduce the conversion of codeine to morphine and may reduce the analgesic effectiveness of the codeine component.
Frequently asked questions about Migraleve Pink
What is Migraleve Pink used for?
Migraleve Pink is licensed for the short-term treatment of acute migraine attacks in adults and adolescents aged 12 and over. The pink tablets treat both pain and the nausea or vomiting of migraine at the start of an attack. It's not licensed for tension headaches or non-migraine pain on a routine basis.
How do I know if I'm having a migraine?
Migraines typically involve moderate-to-severe pulsating headache (often one-sided), nausea, sensitivity to light and sound, and sometimes visual aura (zigzag patterns, blind spots). Attacks usually last 4 to 72 hours. If you're not sure whether your headaches are migraine, see your GP for a proper diagnosis before self-treating regularly.
What's the difference between Migraleve Pink and Migraleve Complete?
Migraleve Pink contains only the pink tablets (paracetamol, codeine, and buclizine) for use at the start of a migraine attack. Migraleve Complete is a combination pack containing both pink tablets and yellow tablets (paracetamol and codeine only), giving you a two-step approach with continued pain relief through the attack. If you typically need follow-up cover four hours after the onset dose, the Complete pack is usually the better option.
Why can I only take 2 Migraleve Pink tablets in 24 hours?
The buclizine antihistamine content is the limiting factor. Repeating buclizine within the same 24-hour period can cause excessive drowsiness, dry mouth, urinary retention, and confusion, particularly in older adults. The buclizine in your initial pink dose lasts several hours, so a single dose at attack onset is usually enough for the nausea side of things.
Can I take Migraleve Pink with paracetamol or co-codamol?
No, never combine Migraleve Pink with other paracetamol-containing products. Migraleve Pink already contains 500mg of paracetamol per tablet, and accidentally exceeding 4g of paracetamol in 24 hours can cause severe liver injury. Read labels on cold-and-flu products, co-codamol, Solpadeine, and similar very carefully.
Can I take Migraleve Pink with ibuprofen?
Yes, ibuprofen works on a different pathway and can be taken alongside Migraleve Pink. Some people find this combination more effective for severe migraine than either alone. Stick to standard ibuprofen dosing (200 to 400mg up to three times daily with food) and mention everything you take during your consultation.
How quickly does Migraleve Pink work?
Most people notice the pain easing within 30 to 60 minutes of the pink tablets. The anti-nausea effect of buclizine can start within 30 minutes and lasts several hours. Taking the tablets at the very first sign of an attack (during aura if you experience one) gives the best chance of aborting or significantly reducing the headache.
What if my migraine pain comes back later in the day?
If pain returns four hours after the pink dose and within the same 24-hour window, the appropriate follow-up is either Migraleve Yellow (paracetamol and codeine only, without buclizine) up to 6 yellow tablets in 24 hours, or a paracetamol-free option like ibuprofen taken in line with its own dosing rules. Don't take a second dose of Migraleve Pink within 24 hours of the first.
Can I take Migraleve Pink long-term?
No. Migraleve Pink must not be used for more than three days continuously without medical advice. Codeine carries addiction risk, and regular use of painkillers for headache can cause medication-overuse headache, where the medicine itself drives more headaches. If you're using Migraleve Pink more than twice a week, ask a clinician about preventive treatment.
Can Migraleve Pink make me drowsy?
Yes. The buclizine in the pink tablets is sedating, and codeine can add to that. Don't drive or operate machinery for several hours after taking Migraleve Pink. Many people find the drowsiness helpful for resting through a migraine, but it's worth knowing about before the first dose.
Can children take Migraleve Pink?
Migraleve Pink is suitable for adults and adolescents aged 12 and over. Children under 12 should not take Migraleve because of codeine breathing risks. Children and adolescents under 18 who have had tonsils or adenoids removed for obstructive sleep apnoea must also not take Migraleve.
Can I drink alcohol with Migraleve Pink?
No. Alcohol significantly increases the risks of both paracetamol-related liver injury and codeine-related sedation and breathing depression. Avoid alcohol while taking Migraleve Pink. If you've had alcohol earlier in the day and are now in a migraine attack, paracetamol-only options without codeine may be safer until the alcohol has cleared.
Will Migraleve Pink interact with antidepressants?
It depends on the antidepressant. SSRIs can affect codeine metabolism and add to bleeding risk. MAOIs interact unpredictably with codeine and must not be taken within two weeks of Migraleve Pink. Tricyclic antidepressants compound buclizine's anticholinergic effects. Tell us about every antidepressant during your consultation.
Is Migraleve Pink safe in pregnancy?
Migraleve Pink is not recommended in pregnancy without medical advice. Codeine in particular can cause withdrawal symptoms in newborns if used regularly late in pregnancy. Migraleve Pink must not be used while breastfeeding because codeine passes into breast milk and can cause serious effects in babies.
Will Migraleve Pink cause constipation?
Codeine is a common cause of constipation, even at the low 8mg dose in Migraleve Pink. Short-term use rarely causes a problem, but anyone who uses Migraleve repeatedly may notice it. Staying well hydrated and including fibre in your diet helps; consult a pharmacist if constipation persists.
Can people with MCAS take Migraleve Pink?
Some people with MCAS tolerate Migraleve Pink well; others react to codeine, to excipients, or to the buclizine. We always review the full ingredient list during your consultation if you have known mast cell reactivity, and where appropriate we can discuss whether a different acute migraine treatment suits you better.
What is medication-overuse headache?
Medication-overuse headache is a paradox: using painkillers regularly for headache eventually causes more headaches. Codeine-containing products like Migraleve Pink are particularly likely to cause this. If you find yourself needing migraine treatment most days, see a clinician about prevention rather than escalating your acute treatment.
Should I see a doctor about my migraines?
If migraines are frequent (more than twice a month), severe, changing pattern, or interfering significantly with daily life, see your GP. They can confirm the diagnosis, rule out other causes if needed, and discuss preventive treatment and triptans, which are migraine-specific prescription medicines. Migraleve Pink is for acute treatment, not prevention.
How is Migraleve Pink stored?
Store below 25°C, in the original packaging, away from direct sunlight. Keep out of sight and reach of children. The codeine content means safe storage matters more than for some other medicines. Return any unused tablets to a pharmacy for safe disposal rather than household waste.
What happens if I take too much Migraleve Pink?
Seek immediate medical advice, even if you feel okay. Paracetamol overdose can cause severe liver damage that may not be apparent for hours. Codeine overdose can cause drowsiness, breathing problems, and unconsciousness. Take the packaging with you to the hospital or call 999.
How do I order Migraleve Pink from Courier Pharmacy?
Complete the short online consultation on our site, and a UK GPhC-registered pharmacist will review your answers, paying particular attention to codeine safety. If Migraleve Pink is suitable, your order is approved, our pharmacy dispenses your pack and delivers it discreetly to your door. If it isn't suitable, we'll tell you why.
Disclaimer: This article is for general information only and isn’t a substitute for personal medical advice, diagnosis, or treatment. Always check with a GP, pharmacist, or specialist before starting a new supplement if you have a medical condition or take regular medicines.
More than a prescription: our community
Healthcare shouldn't only happen when you're paying for it. Every fortnight we run free drop-in talks and clinics at Insomnia, Derby, from 10 am to 12 pm. Bring a question, bring a friend, bring a stack of bewildering letters from another clinic; we'll sit with you. We cover migraine, chronic pain, hair loss, men's health, MCAS, fibromyalgia, low-dose naltrexone, and whatever else people bring through the door. No appointment. No cost. No pressure. Learn more about our community talks.
How this content was created
Written by the Courier Pharmacy editorial team and reviewed by a GPhC-registered pharmacist. Grounded in the latest NHS, NICE, BNF and EMC guidance, peer-reviewed studies, and the real questions patients bring to our drop-in clinics in Derby.
